Merck KGaA Logo

Merck KGaA

6MK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 East Lincoln Avenue, 07065-1310 Rahway
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India and in the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Merck KGaA. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-07 11:28
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-04 13:25
Declaration of Voting Results & Voting Rights Announcements
English 81.3 KB
2025-07-03 10:58
Declaration of Voting Results & Voting Rights Announcements
English 75.7 KB
2025-06-13 15:37
Major Shareholding Notification
English 12.2 KB
2025-06-13 13:23
Declaration of Voting Results & Voting Rights Announcements
English 13.3 KB
2025-06-10 10:31
Declaration of Voting Results & Voting Rights Announcements
English 78.1 KB
2025-06-05 08:43
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-05-19 00:00
Quarterly Report
Q1 statement / Q1 financial report 2025
English 809.0 KB
2025-05-06 13:33
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-26 14:13
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-24 22:45
M&A Activity
Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics…
English 5.3 KB

Automate Your Workflow. Get a real-time feed of all Merck KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Merck KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genmab Logo
Develops antibody therapeutics for cancer and serious diseases using proprietary technology.
Denmark GMAB
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
genOway Logo
Develops genetically engineered preclinical models for biopharma and academic research.
France ALGEN
GenSight Biologics S.A. Logo
Biopharma developing gene therapies for retinal neurodegenerative diseases and CNS disorders.
France SIGHT
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Guard Therapeutics International AB Logo
Clinical-stage biotech developing protein-based therapies for acute kidney injury.
Sweden GUARD
Gubra A/S Logo
Preclinical CRO and peptide drug developer for metabolic and fibrotic diseases.
Denmark GUBRA
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops novel therapies for life-threatening blood disorders, cancers, and autoimmune diseases.
United Kingdom HEMO